Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - CAPITAL EXPENDITURES
Capital Expenditures CRVS - Corvus Pharmaceuticals, Inc.
-34 K
LAST VALUE
-160.77%
2 YEAR CAGR
37.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR